ATE322900T1 - Deoxynojirimycin derivate und ihre verwendung als glukosesylceramidase-inhibitoren - Google Patents

Deoxynojirimycin derivate und ihre verwendung als glukosesylceramidase-inhibitoren

Info

Publication number
ATE322900T1
ATE322900T1 AT97930879T AT97930879T ATE322900T1 AT E322900 T1 ATE322900 T1 AT E322900T1 AT 97930879 T AT97930879 T AT 97930879T AT 97930879 T AT97930879 T AT 97930879T AT E322900 T1 ATE322900 T1 AT E322900T1
Authority
AT
Austria
Prior art keywords
glucosesylceramidase
inhibitors
deoxynojirimycin
deoxynojirimycin derivatives
derivatives
Prior art date
Application number
AT97930879T
Other languages
English (en)
Inventor
Johannes Maria Franciscu Aerts
Meibergdreef
Upendra Kumar Pandit
Gerrit Jan Koomen
Herman Steven Overkleeft
Paola Vianello
Original Assignee
Macrozyme Dnm B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macrozyme Dnm B V filed Critical Macrozyme Dnm B V
Application granted granted Critical
Publication of ATE322900T1 publication Critical patent/ATE322900T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
AT97930879T 1996-07-15 1997-07-14 Deoxynojirimycin derivate und ihre verwendung als glukosesylceramidase-inhibitoren ATE322900T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96202010 1996-07-15

Publications (1)

Publication Number Publication Date
ATE322900T1 true ATE322900T1 (de) 2006-04-15

Family

ID=8224192

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97930879T ATE322900T1 (de) 1996-07-15 1997-07-14 Deoxynojirimycin derivate und ihre verwendung als glukosesylceramidase-inhibitoren

Country Status (9)

Country Link
US (1) US6177447B1 (de)
EP (1) EP0912179B1 (de)
JP (5) JP4564108B2 (de)
AT (1) ATE322900T1 (de)
AU (1) AU732552B2 (de)
CA (1) CA2260790C (de)
DE (1) DE69735669T2 (de)
IL (1) IL128036A (de)
WO (1) WO1998002161A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6098631A (en) * 1998-01-21 2000-08-08 The Regents Of The University Of Michigan Compositions and methods for treating autoimmune disease
US6274597B1 (en) * 1998-06-01 2001-08-14 Mount Sinai School Of Medicine Of New York University Method of enhancing lysosomal α-Galactosidase A
US6610703B1 (en) * 1998-12-10 2003-08-26 G.D. Searle & Co. Method for treatment of glycolipid storage diseases
GB0100889D0 (en) * 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
GB9909064D0 (en) 1999-04-20 1999-06-16 Oxford Glycosciences Uk Ltd Therapies
GB9909066D0 (en) * 1999-04-20 1999-06-16 Oxford Glycosciences Uk Ltd Therapies
EP1196190B1 (de) 1999-07-26 2003-03-19 G.D. SEARLE & CO. Verwendung von langkettigen n-alkyl derivaten von deoxynojirimycin mit glucocerebrosidase enzyme zur herstellung eines medikaments zur behandlung von mit glykolipiden akkumulation zusammenhängenden krankheiten
US7182953B2 (en) * 1999-12-15 2007-02-27 Celgene Corporation Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders
AU2001236713A1 (en) * 2000-02-17 2001-08-27 Genzyme Corporation Methods for treatment of lysosomal storage diseases
AU2001269923A1 (en) * 2000-06-19 2002-01-02 Genzyme Corporation Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
US7138262B1 (en) * 2000-08-18 2006-11-21 Shire Human Genetic Therapies, Inc. High mannose proteins and methods of making high mannose proteins
WO2003032946A2 (en) * 2001-10-12 2003-04-24 United Therapeutics Corporation Ph-sensitive liposomes for targeted drug delivery
US7994198B2 (en) 2002-07-17 2011-08-09 Actelion Pharmaceuticals Ltd. Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase
AU2003246942B2 (en) 2002-07-17 2009-06-25 Idorsia Pharmaceuticals Ltd Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
GB0313678D0 (en) 2003-06-13 2003-07-16 Oxford Glycosciences Uk Ltd Novel compounds
GB0313677D0 (en) 2003-06-13 2003-07-16 Oxford Glycosciences Uk Ltd Novel compound
EP1528056A1 (de) * 2003-10-29 2005-05-04 Academisch Ziekenhuis bij de Universiteit van Amsterdam Deoxynojirimycin Derivate und ihre Verwendung als Glukosesylceramidase-Inhibitoren
WO2005039578A2 (en) * 2003-10-29 2005-05-06 Macrozyme B.V. Use of a deoxynojirimycin derivative or a pharmaceutically salt thereof
CA2545433A1 (en) * 2003-11-12 2005-05-26 Amicus Therapeutics Inc. Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease
WO2005063706A1 (en) * 2003-12-23 2005-07-14 Macrozyme Dnm B.V. Synthesis of nojirimycins
US20090111812A1 (en) * 2004-06-14 2009-04-30 Musc Foundation For Research Development Methods for treating inflammatory disorders
HRP20120994T1 (hr) 2006-02-07 2012-12-31 Shire Human Genetic Therapies, Inc. Stabilizirana smjesa glukocerebrozidaze
DE602007008870D1 (de) 2006-04-24 2010-10-14 Amc Amsterdam Verbessertes verfahren zur behandlung von cystischer fibrose
US8426395B2 (en) * 2008-05-30 2013-04-23 Northern Northern Innovations Holding Corp Preparations containing creatine and imino sugars
EP2411526A4 (de) * 2009-03-27 2012-09-19 Zacharon Pharmaceuticals Inc Modulatoren der gangliosidenbiosynthese
NZ713967A (en) 2009-07-28 2017-01-27 Shire Human Genetic Therapies Compositions and methods for treating gaucher disease
EP2595651B1 (de) 2010-07-19 2017-03-29 Shire Human Genetic Therapies, Inc. Kodonoptimierte zelllinie für den mannoserezeptor-c vom typ 1 (mrc1) und anwendungen davon
CN104519905A (zh) 2012-03-02 2015-04-15 夏尔人类遗传性治疗公司 用于治疗iii型戈谢病的组合物和方法
KR20150035767A (ko) * 2012-06-06 2015-04-07 유니터 바이롤로지, 엘엘씨 신규 이미노당 및 그의 용도
WO2014017915A2 (en) * 2012-07-27 2014-01-30 Universiteit Utrecht Holding B.V. Urea and guanidinium derivatives of iminosugars
EP3461812B1 (de) 2014-03-27 2021-10-13 Academisch Medisch Centrum N-(5-(biphen-4-ylmethyloxy)pentyl)-substituierte iminozucker als glucosylceramid-synthase-hemmer
CN107949380B (zh) * 2015-02-11 2021-07-06 西奈山伊坎医学院 用于尼曼-匹克病和其他溶酶体贮积症的npc1的苯磺酰胺上调剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2925943A1 (de) * 1979-06-27 1981-01-29 Bayer Ag 1-alkadien-2,4-yl-2-hydroxymethyl3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3007078A1 (de) * 1980-02-26 1981-09-10 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
DE3024901A1 (de) * 1980-07-01 1982-01-28 Bayer Ag, 5090 Leverkusen Herbizide mittel auf basis von piperidin-derivaten
DE3507019A1 (de) * 1985-02-28 1986-08-28 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung
US4880902A (en) 1987-08-27 1989-11-14 Shell Oil Company Copolymerization of carbon monoxide and olefin with diphosphine having heterocyclic substituents as catalyst
EP0350012A3 (de) * 1988-07-08 1990-09-05 Meiji Seika Kaisha Ltd. Antivirale Zusammensetzung
JPH02306962A (ja) 1989-05-19 1990-12-20 Meiji Seika Kaisha Ltd 新規ｎ―置換―１―デオキシノジリマイシン誘導体及びそれを含有する癌細胞転移抑制剤
ES2087277T3 (es) 1990-09-20 1996-07-16 Monsanto Co Procedimiento para producir 1-desoxinojirimicina n-sustituida.
DK0675727T3 (da) 1992-12-10 2002-08-05 Enzon Inc Glycolipidenzympolymerkonjugater
US5429177A (en) 1993-07-09 1995-07-04 Sierra Regenators, Inc. Foil regenerator
AU1876095A (en) * 1994-02-25 1995-09-11 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus

Also Published As

Publication number Publication date
DE69735669T2 (de) 2007-03-29
JP2010031062A (ja) 2010-02-12
IL128036A0 (en) 1999-11-30
EP0912179B1 (de) 2006-04-12
DE69735669D1 (de) 2006-05-24
IL128036A (en) 2005-08-31
JP2016056203A (ja) 2016-04-21
JP2014024857A (ja) 2014-02-06
WO1998002161A1 (en) 1998-01-22
AU732552B2 (en) 2001-04-26
CA2260790A1 (en) 1998-01-22
CA2260790C (en) 2007-01-09
AU3464797A (en) 1998-02-09
JP4564108B2 (ja) 2010-10-20
EP0912179A1 (de) 1999-05-06
JP2017122133A (ja) 2017-07-13
US6177447B1 (en) 2001-01-23
JP2000516577A (ja) 2000-12-12

Similar Documents

Publication Publication Date Title
ATE322900T1 (de) Deoxynojirimycin derivate und ihre verwendung als glukosesylceramidase-inhibitoren
DK0891331T3 (da) N-(2-Oxoacetyl- eller sulfonyl)pyrrolidin/piperidin-2-carboxylsyrederivater med forbedret multi-lægemiddelresistensaktivitet
DE69717148D1 (de) 3-pyridylenantiomere und ihre verwendung als analgetika
BR0016693A (pt) Derivados de pirrolidina como inibidores de fosfodiesterase especìfico amp cìclico
DK0662958T3 (da) 1-(2-Oxoacetyl)piperidin-2-carboxylsyrederivater som multilægemiddelresistente cancercellesensibiliserende midler
DE59608740D1 (de) Cyclische und heterocyclische n-substituierte alpha-iminohydroxam- und carbonsäuren
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
DK256890D0 (da) Benzo-piperidin-, -piperidyliden- og piperazinforbindelser, kompositioner indeholdende forbindelserne og fremgangsmaader til forbindelsernes fremstilling og anvendelse
DE60105144D1 (de) Pyrrolidin und piperidin derivate für die behandlung von neurodegenerativen erkrankungen
NO965094L (no) [aÅ-annelerte pyrrolderivater og anvendelse av disse i farmasien
NO963731L (no) Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister
BR0016687A (pt) Pirrolidinas que inibem a pde especìfica do ampc
NO965093L (no) [aÅ-annelerte pyrrolderivater og anvendelse av disse i farmasien
WO1999026932A8 (en) By amidino group substituted heterocyclic derivatives and their use as anticoagulants
ATA903796A (de) Elektrotransporteinrichtung zur verabreichung eines als fentanylsalz oder als sufentanilsalz vorliegenden analgetischen medikaments
EA200000204A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
ATE188873T1 (de) Tris-platin-komplexe
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
TR200100055T2 (tr) Paroksetin tuzları
PT1152762E (pt) Utilizacao de desoxipeganina no tratamento da demencia de alzheimer
NO982863L (no) Nye forbindelser med analgetisk effekt
IL106237A0 (en) Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis
GEP19991780B (en) Use of Pyrrolidine Derivatives for Treating Alcoholism
DE69504198D1 (de) Substituierte alkyldiaminderivate und ihre verwendung als tachykinin antagonisten
FR2795645B1 (fr) Nouvelle association pharmaceutique a activite analgesique

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties